COBRE: HIF-1: THERAPEUTIC TARGET IN DIABETIC RETINOPATHY

$210,250P20FY2004RRNIH

University Of Oklahoma Hlth Sciences Ctr, Oklahoma City OK

Investigators

Michael A Ihnat

Linked publications & trials

Paper 29969487 Paper 28351530 Paper 26947037 Paper 26893377 Paper 26662863 Paper 26427466 Paper 26427405 Paper 26325328 Paper 25406276 Paper 24964953 Paper 24959742 Paper 24833735 Paper 24764063 Paper 24722693 Paper 24664777 Paper 24664753 Paper 24664752 Paper 24664751 Paper 24664730 Paper 24664681 Paper 24664676 Paper 24644051 Paper 24588082 Paper 24569140 Paper 24550448 Paper 24140045 Paper 24027293 Paper 24011710 Paper 23993956 Paper 23978600 Paper 23844743 Paper 23843879 Paper 23840687 Paper 23740940 Paper 23673657 Paper 23536794 Paper 23509295 Paper 23501591 Paper 23468130 Paper 23275801 Paper 23142158 Paper 23036996 Paper 23032687 Paper 23028906 Paper 22959465 Paper 22829597 Paper 22745813 Paper 22715395 Paper 22714890 Paper 22690111 Paper 22649204 Paper 22645143 Paper 22577078 Paper 22532684 Paper 22493484 Paper 22474484 Paper 22451674 Paper 22247469 Paper 22236996 Paper 22201850 Paper 22183414 Paper 22183405 Paper 22183377 Paper 22183346 Paper 22183326 Paper 22163046 Paper 22158834 Paper 22102283 Paper 22020534 Paper 21998580 Paper 21791595 Paper 21730346 Paper 21606892 Paper 21576125 Paper 21398281 Paper 21396448 Paper 21394081 Paper 21364932 Paper 21360191 Paper 21273547 Paper 21253511 Paper 21178141 Paper 21147921 Paper 21039965 Paper 20806040 Paper 20617106 Paper 20605566 Paper 20530741 Paper 20457154 Paper 20434439 Paper 20407846 Paper 20393115 Paper 20299492 Paper 20298786 Paper 20238070 Paper 20238060 Paper 20238035 Paper 20238023 Paper 20238022 Paper 20238019

View original record on NIH RePORTER →